© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
IV Ibuprofen Cuts Postop Opioid Use by 23% in Older Adults, Study Finds
May 28, 2025
The opioid-sparing IVIB pain management strategy in adults aged 60 and older was effective in the immediate post-surgical period and associated with limited AEs.
Telehealth Reduces Antibiotic Use for Pediatric ARTIs in Primary Care: Daily Dose
May 28, 2025
Your daily dose of the clinical news you may have missed.
Tailoring Weight Management Conversations Across a Woman’s Lifespan
May 27, 2025
Johanna Finkle, MD, outlines how clinicians can adapt weight management counseling during key stages of a woman’s life, from preconception through menopause.
FDA Advisory Panel Recommends Continued Use of Monovalent JN.1 Strain for COVID-19 Vaccines
May 27, 2025
FDA panel endorses continued use of monovalent JN.1 strain for COVID-19 vaccines, aligning with global health recommendations amid evolving variants.
Novel 5-HT2A Agonist GM-2505 Achieves 94% Remission Rate in Phase 2a MDD Trial, With Rapid and Durable Efficacy
May 27, 2025
The novel rapid-acting psychedelic agent produced antidepressant effects within 24 hours after the first infusion, with a -18.5 point change in MADRS from baseline.
Telehealth May Represent Up to 30% of US Medical Visits by 2026
May 27, 2025
Telemedicine's trajectory depends far more on future regulatory action than on health care's readiness or patient desire, according to a new report.
Dupilumab for Severe COPD Shows Efficacy, Tolerability, Patient Satisfaction in New Real-World Study
May 27, 2025
Dupilumab significantly reduced COPD exacerbations and received high satisfaction ratings from patients with severe disease and Th2 inflammation.
FDA Clears First At-Home Pap Smear Alternative for Cervical Cancer Screening: Daily Dose
May 27, 2025
Your daily dose of the clinical news you may have missed.
Combined Oral Contraceptive Use May Triple the Risk of Cryptogenic Stroke in Young Women
May 23, 2025
ESOC 2025: New research reveals that combined oral contraceptive use significantly increases the risk of cryptogenic stroke in young women, urging careful assessment by clinicians.
Mepolizumab Approved as First Biologic to Treat COPD with Eosinophilic Phenotype
May 23, 2025
Mepolizumab, an IL-5 inhibitor targeting Th2 inflammation characterized by elevate serum eosinophil count, fills a treatment gap for ~70% of adults with uncontrolled COPD.